Basel Medical Group Ltd(BMGL)
$0.47-0.10 (-17.54%)
BMGL
Basel Medical Group Ltd financials statements
$0.47
At close:-0.10 (-17.54%)
Basel Medical Group Ltd (BMGL) Ratios
85 Followers
Basel Medical Group Ltd Ratios
BMGL's free cash flow for Q4 2025 was S$440.98K. For the 2025 fiscal year, BMGL's free cash flow was decreased by S$-61.61K and operating cash flow was S$993.45K. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.23 | 1.23 | 2.26 | 2.28 | 2.18 |
| Quick Ratio | 1.21 | 1.19 | 2.25 | 2.27 | 2.17 |
| Cash Ratio | 0.05 | 0.28 | 0.27 | 0.19 | 0.22 |
| Solvency Ratio | -0.03 | -0.91 | 0.30 | 0.24 | 0.19 |
| Operating Cash Flow Ratio | -0.06 | -0.41 | 0.35 | 0.40 | 0.39 |
| Short-Term Operating Cash Flow Coverage | -0.10 | -70.78 | 0.94 | 0.81 | 0.77 |
| Net Current Asset Value | S$ -1.12M | S$ 1.13M | S$ 7.43M | S$ 4.88M | S$ 2.52M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.54 | 0.20 | 0.26 | 0.47 | 0.60 |
| Debt-to-Equity Ratio | 1.90 | 0.70 | 0.57 | 1.31 | 2.74 |
| Debt-to-Capital Ratio | 0.66 | 0.41 | 0.36 | 0.57 | 0.73 |
| Long-Term Debt-to-Capital Ratio | 0.40 | 0.00 | 0.17 | 0.38 | 0.59 |
| Financial Leverage Ratio | 3.52 | 3.47 | 2.16 | 2.80 | 4.55 |
| Debt Service Coverage Ratio | -0.09 | -40.34 | 0.97 | 0.75 | 0.73 |
| Interest Coverage Ratio | 18.12 | -10.70 | 12.46 | 8.39 | 7.71 |
| Debt to Market Cap | 1.12 | 0.00 | 0.04 | 0.06 | 0.08 |
| Interest Debt Per Share | 10.51 | 2.32 | 0.24 | 0.40 | 0.56 |
| Net Debt to EBITDA | -20.67 | -0.04 | 0.75 | 2.05 | 2.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 38.77% | 77.68% | 77.63% | 75.91% | 79.56% |
| EBIT Margin | -3.67% | -108.67% | 25.68% | 24.43% | 25.40% |
| EBITDA Margin | -2.04% | -98.24% | 30.94% | 30.17% | 30.80% |
| Operating Profit Margin | 38.74% | -19.28% | 21.84% | 20.64% | 23.21% |
| Pretax Profit Margin | -5.81% | -110.47% | 23.92% | 21.97% | 22.39% |
| Net Profit Margin | -3.48% | -106.78% | 20.62% | 18.38% | 18.56% |
| Continuous Operations Profit Margin | -6.64% | -106.79% | 20.62% | 18.38% | 18.56% |
| Net Income Per EBT | 59.85% | 96.66% | 86.20% | 83.66% | 82.88% |
| EBT Per EBIT | -15.00% | 572.85% | 109.54% | 106.42% | 96.45% |
| Return on Assets (ROA) | -4.21% | -71.72% | 12.71% | 11.59% | 11.74% |
| Return on Equity (ROE) | -14.79% | -248.66% | 27.41% | 32.49% | 53.38% |
| Return on Capital Employed (ROCE) | 105.14% | -35.42% | 24.00% | 22.47% | 25.62% |
| Return on Invested Capital (ROIC) | 58.87% | -25.47% | 15.97% | 13.19% | 14.80% |
| Return on Tangible Assets | -4.21% | -71.72% | 12.71% | 11.59% | 11.74% |
| Earnings Yield | -8.67% | -28.44% | 1.84% | 1.58% | 1.71% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.08 | 4.54 | 0.81 | 0.73 | 0.77 |
| Payables Turnover | 3.71 | 1.20 | 2.71 | 1.60 | 2.02 |
| Inventory Turnover | 57.04 | 6.71 | 31.21 | 24.70 | 31.20 |
| Fixed Asset Turnover | 3.84 | 3.28 | 173.37 | 16.76 | 9.05 |
| Asset Turnover | 1.21 | 0.67 | 0.62 | 0.63 | 0.63 |
| Working Capital Turnover Ratio | 9.17 | 1.98 | 1.16 | 1.16 | 0.00 |
| Cash Conversion Cycle | 83.38 | -168.23 | 328.95 | 287.52 | 306.40 |
| Days of Sales Outstanding | 175.46 | 80.44 | 451.91 | 501.44 | 475.45 |
| Days of Inventory Outstanding | 6.40 | 54.37 | 11.69 | 14.78 | 11.70 |
| Days of Payables Outstanding | 98.48 | 303.04 | 134.65 | 228.69 | 180.75 |
| Operating Cycle | 181.86 | 134.81 | 463.60 | 516.22 | 487.15 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.66 | -2.78 | 0.13 | 0.14 | 0.15 |
| Free Cash Flow Per Share | -0.92 | -2.81 | 0.13 | 0.14 | 0.14 |
| Dividend Paid and CapEx Coverage Ratio | -2.56 | -79.33 | 316.83 | 421.94 | 31.56 |
| Capital Expenditure Coverage Ratio | -2.56 | -79.33 | 316.83 | 421.94 | 31.56 |
| Operating Cash Flow Coverage Ratio | -0.07 | -1.27 | 0.58 | 0.36 | 0.28 |
| Operating Cash Flow to Sales Ratio | -0.03 | -0.38 | 0.25 | 0.27 | 0.26 |
| Free Cash Flow Yield | -10.25% | -10.35% | 2.22% | 2.30% | 2.34% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -18.73 | -3.90 | 54.43 | 63.13 | 58.47 |
| Price-to-Sales (P/S) Ratio | 0.40 | 3.75 | 11.23 | 11.60 | 10.85 |
| Price-to-Book (P/B) Ratio | 1.71 | 8.74 | 14.92 | 20.51 | 31.21 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -9.76 | -9.66 | 45.11 | 43.40 | 42.77 |
| Price-to-Operating Cash Flow Ratio | -13.58 | -9.78 | 44.96 | 43.30 | 41.42 |
| Price-to-Earnings Growth (PEG) Ratio | 0.20 | 0.01 | 3.47 | -4.66 | 0.00 |
| Enterprise Value Multiple | -40.27 | -3.86 | 37.04 | 40.50 | 37.84 |
| Enterprise Value | 17.71M | 42.94M | 115.17M | 118.57M | 124.25M |
| EV to EBITDA | -40.27 | -3.86 | 37.04 | 40.50 | 37.84 |
| EV to Sales | 0.82 | 3.79 | 11.46 | 12.22 | 11.66 |
| EV to Free Cash Flow | -20.05 | -9.76 | 46.04 | 45.71 | 45.95 |
| EV to Operating Cash Flow | -27.88 | -9.88 | 45.90 | 45.60 | 44.49 |
| Tangible Book Value Per Share | 4.73 | 3.11 | 0.40 | 0.29 | 0.20 |
| Shareholders’ Equity Per Share | 5.27 | 3.11 | 0.40 | 0.29 | 0.20 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.14 | 0.03 | 0.14 | 0.16 | 0.17 |
| Revenue Per Share | 22.43 | 7.23 | 0.54 | 0.52 | 0.57 |
| Net Income Per Share | -0.78 | -7.72 | 0.11 | 0.10 | 0.11 |
| Tax Burden | 0.60 | 0.97 | 0.86 | 0.84 | 0.83 |
| Interest Burden | 1.58 | 1.02 | 0.93 | 0.90 | 0.88 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.43 | 0.58 | 0.36 | 0.34 | 0.38 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.85 | 0.35 | 1.04 | 1.22 | 1.17 |
Currency in SGD

